Rite Aid

Rite Aid Corp. engages in the ownership and management of retail drug stores. It operates through following segments: Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment includes branded and generic prescription drugs, health and beauty aids, personal care products, and walk-in retail clinics. The Pharmacy Services segment offers transparent and traditional pharmacy benefit management for insurance companies, employers, health plans, and government employee groups. The company was founded by Alex Grass on September 12, 1962 and is headquartered in Philadelphia, PA.

Earnings data Q1 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Rite Aid is a drugstore chain that offers prescription medications, over-the-counter drugs, and health and wellness products. Rite Aid is reshaping the concept of a modern pharmacy by catering to customer demands through various convenient channels, including retail and delivery pharmacy services. Additionally, the company's offerings extend to services provided by its wholly-owned subsidiaries, namely Elixir, Bartell Drugs, and Health Dialog. Elixir, Rite Aid’s pharmacy benefits and services company, encompasses accredited mail and specialty pharmacies, prescription discount programs, and an advanced adjudication platform. These components combine to provide exceptional member experiences and substantial cost savings. Furthermore, Health Dialog delivers healthcare coaching and disease management services through interactive live online sessions and phone-based health services.

Rite Aid is a health products and services company with 2,400 locations across 17 states.

The company's omnichannel business includes digital, retail, and delivery touchpoints. Rite Aid is a top 20 seller of speciality medications, per its investor website.

In addition to its retail business, Rite Aid owns a pharmacy benefits subdivision (Elixir) and a personalized health services and coaching arm, Health Dialog, which has served 10MM members as of May 2022.

The company has reported $1.85 billion of liquidity with no debt maturities until 2025. According to its investor website, Rite Aid expects to be free cash flow (FCF) positive in FY23.

In Q2 2022, Rite Aid shared a three-part growth strategy aimed at deepening market share, expanding into new markets, and creating new offerings.

To grow the current business, Rite Aid is aiming to increase its e-commerce and digital sales, refresh its loyalty program, and grow its specialty pharmacy offering, which focuses on serving customers with complex health conditions.

New market expansion plans include increasing Rite Aid's footprint of "small format" pharmacies in underserved communities and implementing "store within a store" partnerships.

Rite Aid also aims to grow via new offerings, such as expanded health plan and health system clinical services, a pharmacy benefit manager (PBM) as a service offering, and new strategic partnerships.

Rite Aid Investor Relations

*This is not investment advice.

Rite Aid (RAD) reported earnings 30 days ago. What's next for the stock?

Rite Aid (RAD) Down 16.1% Since Last Earnings Report: Can It Rebound?

Although high costs and a drab view remain concerning, Rite Aid (RAD) looks well-positioned on robust demand, enhanced omni-channel capabilities and strength in PBM.

Solid Demand & Other Efforts Aid Rite Aid (RAD) Amid Cost Woes

Rite Aid may form closer ties with the pharmacy benefit manager Prime Therapeutics, which is owned by Blue Cross and Blue Shield plans.

Rite Aid May Form Even Closer Ties With Prime Therapeutics PBM

Increased demand for COVID-19 vaccination and testing, and growth in the Retail Pharmacy unit aid Rite Aid's (RAD) Q3 results.

Rite Aid (RAD) Q3 Earnings Beat Estimates, Revenues Lag

Rite Aid CEO Heyward Donigan said he plans to move away from traditional in-store pharmacies, and instead to mail order and digital retail markets.

Rite Aid says it plans to shut 63 stores — and will likely find even more to close in the coming months

Surging COVID-19 testing and fewer stores could mean more profits for investors.

Why Rite Aid Stock Rocketed Today

Rite Aid Corporation (RAD) CEO Heyward Donigan on Q3 2022 Results - Earnings Call Transcript

Rite Aid Corporation shares were up almost 20% early on Tuesday (Dec. 21) after the company announced it has kicked off a plan to close at least 63 stores across the U.S., a move focused on reducing costs and increasing profitability as much as $25 million.  The company's review of its operations is ongoing and […]

Rite Aid Shares Soar as Chain Announces Store Closure Plan

Rite Aid Corp (NYSE: RAD) is trading higher Tuesday after the company announced its fiscal third-quarter 2022 earnings results and issued guidance above estimates.  Rite Aid reported quarterly adjusted earnings of 15 cents per share, which may not compare to estimates for a loss of 14 cents per share.

Why Rite Aid Shares Are Ripping Higher Today

Rite Aid announced Tuesday it is closing another 63 stores to save about $25 million year.

Rite Aid is closing more than 60 stores

Rite Aid (RAD) delivered earnings and revenue surprises of 183.33% and 0.83%, respectively, for the quarter ended November 2021. Do the numbers hold clues to what lies ahead for the stock?

Rite Aid (RAD) Q3 Earnings Surpass Estimates

Rite Aid Corp  (NYSE: RAD) has reported Q3 FY22 adjusted EPS of $0.15, compared to $0.40 a year ago, but a turnaround from a loss of $(0.41) per share in Q2 FY22. Earnings: Revenues increased 1.8% Y/Y to $6.23 billion, missing the estimate of $6.32 billion.

Rite Aid Q3 Sales Miss Street View; Reveals Store Closure Plan

Drugstore chain Rite Aid said Tuesday it plans to shutter at least 63 stores as it reassesses how many locations it needs in the United States.

Drugstore chain Rite Aid to close at least 63 stores in the coming months

Rite Aid said it will close 63 stores in a cost-cutting move designed to save money and help the chain be more competitive.

Rite Aid To Close More Than 60 Stores

Rite Aid Corp. RAD, +2.90% shares rose 2.4% in Tuesday premarket trading after the pharmacy retailer reported a surprise third-quarter adjusted profit and announced dozens of store closures. Net loss totaled $36.1 million, or 67 cents per share, after net income of $4.3 million, or 8 cents per share, last year.

Rite Aid stock jumps after surprise adjusted profit, store closures announced

CAMP HILL, Pa.--(BUSINESS WIRE)--Rite Aid Corporation (NYSE: RAD) today reported operating results for its third fiscal quarter ended November 27, 2021. For the third quarter, the company reported net loss from continuing operations of $36.1 million, or $0.67 loss per share, Adjusted net income from continuing operations of $8.2 million, or $0.15 income per share, and Adjusted EBITDA from continuing operations of $154.8 million, or 2.5 percent of revenues. “We delivered a solid quarter as we gr

Rite Aid Corporation Reports Fiscal 2022 Third Quarter Results

BlackBerry

General Mills

CarMax

Paychex

The shortened holiday week will see less public offerings and earnings from public companies. The week can still bring plenty of trading opportunities with headlines and catalysts.

5 Companies That Could Beat Earnings Estimates This Week: Rite Aid, BlackBerry And More

The shares of drugstore chain Rite Aid Corporation (NYSE:RAD) are down 2.2% to trade at $11.80 this afternoon, just ahead of the company's third-quarter earnings report -- due out before the open tomorrow.

Struggling Rite Aid Stock Lower Before Earnings

Micron Technology

NIKE

Four companies we have previewed reported quarterly results after markets closed Thursday or before they opened on Friday.

Earnings Preview: General Mills, Micron, Nike, Rite Aid

Rite Aid (RAD) is likely to have gained from strength in PBM, RxEvolution strategy and delivery services in Q3. Rising wage costs and drab front-end same-store sales are likely to have been concerns.

Factors Likely to Influence Rite Aid (RAD) in Q3 Earnings

Rite Aid (RAD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Analysts Estimate Rite Aid (RAD) to Report a Decline in Earnings: What to Look Out for

AutoZone

Best Buy

CVS Health

Home Depot

Kroger

Target

Walgreens

The chief executives of major U.S. retailers including Target, Home Depot, Kroger, CVS Health, Autozone and Best Buy on Thursday urged Congress to take action to address some anonymous online sales, citing the growing impact of organized retail crime.

Major U.S. retailers urge action by Congress on online sellers

Investors need to pay close attention to Rite Aid (RAD) stock based on the movements in the options market lately.

Is the Options Market Predicting a Spike in Rite Aid (RAD) Stock?

Strength in online services and the PBM market will likely aid Rite Aid (RAD) in the times ahead. However, higher costs related to the Bartell acquisition and COVID-19 vaccines remain concerning.

Rite Aid (RAD) Stock Dips 13% YTD: Can It Get Back on Track?

The Zacks Retail Pharmacy and Drugstore industry is gaining from the growing demand for digital healthcare support. Industry players like CVS and RAD are likely to gain the most.

News for Rite Aid Stock (RAD)